Forte Biosciences Inc. Stock News

Forte Biosciences, Inc. (FBRX) CEO Paul Wagner on Q1 2021 Results - Earnings Call Transcript

TORRANCE, Calif.--(BUSINESS WIRE)--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, will be providing first quarter 2021 results and a general b

Forte Biosciences is developing a first-in-class drug for eczema, which affects over 16M patients in the US.

The company's key product candidate is FB-401, a topical live biotherapeutic, with three therapeutic strains of commensal gram-negative bacteria Roseomonas mucosa. FB-401 is being developed in mild to

Two new breakout stocks for Week 13 of 2021 with better than 10% short-term upside potential. This past week one selection gained over 10% with KIRK +16.2% in the early part of the week before giving

TORRANCE, Calif.--(BUSINESS WIRE)--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, will be providing 4Q and full year 2020 results and provide

TORRANCE, Calif.--(BUSINESS WIRE)--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the issuance of equity inducement awards as

FB-401 is a unique approach to atopic dermatitis containing three strains of bacteria that have shown the ability to induce tissue repair and reduce inflammation. FB-401 may present efficacy and safet

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the issuance of an equity ind

Hours after blocking a New York Post article from being shared in tweets and direct messages, raising an outcry from many, Twitter Inc. late Wednesday...

Facebook says it will ban ads on its platform that discourage vaccinations — with an exception carved out for ads about government vaccine policies.

Stifel Financial Corp increased its position in shares of FB Financial Corp (NYSE:FBK) by 3.8% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 29,456 shares of

Public Employees Retirement System of Ohio boosted its holdings in FB Financial Corp (NYSE:FBK) by 16.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securit

Analysts expect that FB Financial Corp (NYSE:FBK) will announce sales of $135.25 million for the current quarter, Zacks reports. Four analysts have provided estimates for FB Financial’s earnings, wi

Issues on the docket include copyright law, regulations tied to prescriptions and unsolicited text messages.